P3 Health Partners Inc. (PIII)

NCM – Real vaqt narxi. Valyuta: USD

3.42

-0.41 (-10.82%)

Bozor ochiq: May 13, 2026, 10:52 AM EDT

16.04.2026

P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for first quarter 2026 on Thursday, May 14, 2026. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health First Quarter 2026 Earnings Conf.

27.03.2026

P3 Health Partners Inc. (PIII) Q4 2025 Earnings Call Transcript

26.03.2026

P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2025, and provided 2026 guidance. "2025 was a year of meaningful progress in repositioning the business. We strengthened our contract economics, improved provider alignment, and built a more disciplined operating foundation. With th.

13.03.2026

P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for fourth quarter and full year 2025 on Thursday, March 26, 2026. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Fourth Quarter.

02.12.2025

P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners (“P3”) (NASDAQ: PIII) and Commonwealth Primary Care ACO (Commonwealth) recently announced the formation of a Joint Venture Management Services Organization (MSO) for its ACO lines of business designed to expand value-based care and enhance support for primary care physicians across Arizona, California, Nevada, Oregon, and North Carolina. This partnership brings together two highly aligned organizations with a shared belief in the power of pri.

24.11.2025

P3 Health Partners to Present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference

Henderson, Nevada--(Newsfile Corp. - November 24, 2025) - P3 Health Partners Inc. (NASDAQ: PIII) ("P3"), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming Noble Capital Markets' 21st Annual Emerging Growth Equity Conference. Management is scheduled to present at the conference on Wednesday, December 3, 2025, at 3:30 p.m.

14.11.2025

P3 Health Partners Inc. (PIII) Q3 2025 Earnings Call Transcript

P3 Health Partners Inc. ( PIII ) Q3 2025 Earnings Call November 14, 2025 8:00 AM EST Company Participants Aric Coffman - CEO, President & Director Amir Bacchus - Co-Founder, Chief Medical Officer & Director Leif Pedersen - Chief Financial Officer Conference Call Participants Gabriella Gabel Joshua Raskin - Nephron Research LLC Ryan Langston - TD Cowen, Research Division David Larsen - BTIG, LLC, Research Division Presentation Operator Good day, and welcome to the P3 Health's Third Quarter 2025 Earnings Call. [Operator Instructions] Please note, this event is being recorded.

Videolar

No Data

There is no data to display

Press-relizlar

26.03.2026

P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2025, and provided 2026 guidance. "2025 was a year of meaningful progress in repositioning the business. We strengthened our contract economics, improved provider alignment, and built a more disciplined operating foundation. With th.

02.12.2025

P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO

13.11.2025

P3 Health Partners Announces Third Quarter 2025 Results

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2025. “Our core business continues to demonstrate positive momentum in the third quarter, driven by the expansion of our Care Enablement Model,” said Aric Coffman, CEO of P3. “Medical cost trends, normalized for prior-year adjustments, remain sta.

28.07.2025

Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.

PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION

P3 Health Partners Inc. (PIII)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

P3 Health Partners Inc. (PIII)

P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call

P3 Health Partners Inc. (PIII) Q4 2025 Earnings Call Transcript

P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results

P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO

P3 Health Partners to Present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference

P3 Health Partners Inc. (PIII) Q3 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results

P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO

P3 Health Partners Announces Third Quarter 2025 Results

Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.

P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call

P3 Health Partners Inc. (PIII) Q4 2025 Earnings Call Transcript

P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results

P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO

P3 Health Partners to Present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference

P3 Health Partners Inc. (PIII) Q3 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results

P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO

P3 Health Partners Announces Third Quarter 2025 Results

Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.

Search stocks

P3 Health Partners Inc. (PIII)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

P3 Health Partners Inc. (PIII)

P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call

P3 Health Partners Inc. (PIII) Q4 2025 Earnings Call Transcript

P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results

P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO

P3 Health Partners to Present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference

P3 Health Partners Inc. (PIII) Q3 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results

P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO

P3 Health Partners Announces Third Quarter 2025 Results

Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.

P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call

P3 Health Partners Inc. (PIII) Q4 2025 Earnings Call Transcript

P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results

P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO

P3 Health Partners to Present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference

P3 Health Partners Inc. (PIII) Q3 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results

P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO

P3 Health Partners Announces Third Quarter 2025 Results

Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.